Status | Study |
Recruiting |
Study Name: Treatment of Cushing's Disease With R-roscovitine Condition: Cushings Disease Date: 2014-05-21 Interventions: Drug: R-roscovitine See Arm Description Other Names: |
Recruiting |
Study Name: Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly Condition: Cushing's Disease Acromegaly Date: 2014-02-10 Interventions: Drug: Pasireotide s.c. To be a |
Withdrawn |
Study Name: Mifepristone in Children With Refractory Cushing's Disease Condition: Cushing's Disease Date: 2013-08-08 Interventions: Drug: mifepristone tablets Other Name: Korlym |
Active, not recruiting |
Study Name: Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease Condition: Cushing's Disease Date: 2013-06-10 Interventions: Drug: Pasireotide with or without cabergoline The trial consists of Pasireotide-untreated patients will |
Completed |
Study Name: An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. Condition: Cushing's Disease Date: 2012-04-12 Interventions: Drug: Pasireotide sub-cutaneous formulation Pasireotide will be administered twice a day until pasireoti |
Completed |
Study Name: Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease Condition: Cushing's Disease Date: 2011-06-14 Interventions: Drug: SOM230 LAR 30 mg startin |
Active, not recruiting |
Study Name: Safety and Efficacy of LCI699 in Cushing's Disease Patients. Condition: Cushing's Disease Date: 2011-04-06 Interventions: Drug: LCI699 |
Completed |
Study Name: Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor Condition: Cushing's Disease Corticotroph Adenoma Date: 2009-04-27 Interventions: Drug: Cabergoline Dose 1 mg/week in divided doses, increased by 1 mg/week every month, to the maximum of |
Terminated |
Study Name: Long-term Cardiovascular Risk in Cured Cushing's Patients Condition: Cushing's Disease Date: 2009-04-13 |
Withdrawn |
Study Name: Preoperative Bexarotene Treatment for Cushing's Disease Condition: Cushing's Disease Date: 2009-02-16 Interventions: Drug: Bexarotene bexarotene at 300 mg/m2/day |